Natixis Advisors’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
42,156
+2,426
| +6% | +$178K | ﹤0.01% | 965 |
|
|
2025
Q1 | $4.54M | Buy |
39,730
+7,607
| +24% | +$869K | 0.01% | 839 |
|
|
2024
Q4 | $1.62M | Buy |
32,123
+3,979
| +14% | +$201K | ﹤0.01% | 1165 |
|
|
2024
Q3 | $1.3M | Buy |
28,144
+7,484
| +36% | +$346K | ﹤0.01% | 1222 |
|
|
2024
Q2 | $671K | Buy |
20,660
+2,854
| +16% | +$92.7K | ﹤0.01% | 1367 |
|
|
2024
Q1 | $449K | Sell |
17,806
-4,101
| -19% | -$103K | ﹤0.01% | 1418 |
|
|
2023
Q4 | $711K | Sell |
21,907
-1,886
| -8% | -$61.2K | ﹤0.01% | 1312 |
|
|
2023
Q3 | $648K | Buy |
23,793
+4,921
| +26% | +$134K | ﹤0.01% | 1294 |
|
|
2023
Q2 | $420K | Sell |
18,872
-1,615
| -8% | -$35.9K | ﹤0.01% | 1372 |
|
|
2023
Q1 | $444K | Buy |
20,487
+5,710
| +39% | +$124K | ﹤0.01% | 1337 |
|
|
2022
Q4 | $300K | Sell |
14,777
-4,123
| -22% | -$83.7K | ﹤0.01% | 1392 |
|
|
2022
Q3 | $485K | Buy |
18,900
+2,400
| +15% | +$61.6K | ﹤0.01% | 1293 |
|
|
2022
Q2 | $392K | Sell |
16,500
-2,081
| -11% | -$49.4K | ﹤0.01% | 1331 |
|
|
2022
Q1 | $418K | Buy |
18,581
+6,726
| +57% | +$151K | ﹤0.01% | 1319 |
|
|
2021
Q4 | $235K | Buy |
+11,855
| New | +$235K | ﹤0.01% | 1339 |
|